FATIGUE AND INSOMNIA IN PARKINSON’S DISEASE: GENERAL MECHANISMS AND ITS CORRECTION
Nowadays Parkinson’s disease (PD) takes the leading position in structure of all neurodegenerative diseases. Despite the predominance of motor disorders in PD in the literature, researchers pay attention to nonmotor signs, among which insomnia and fatigue has an grate impact on the life quality indicators. According to a number of authors, each patient with PD showed the effect of dopaminergic therapy on fatigue, which correlated with the dose of drugs. In recent decades, researchers have shown the efficacy of melatonin for insomnias in PD patients.